[CLDX] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 85.43%
YoY- 88.11%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 3,786 887 1,764 3,456 1,874 1,790 1,477 16.96%
PBT -22,839 -10,447 -9,402 -22,923 -32,307 -32,684 -31,821 -5.37%
Tax -939 -4,448 -8,746 -19,082 -5,090 836 -229 26.48%
NP -21,900 -10,447 -9,402 -3,841 -32,307 -32,684 -31,821 -6.03%
Tax Rate - - - - - - - -
Total Cost 25,686 11,334 11,166 7,297 34,181 34,474 33,298 -4.22%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -578.45 -1,177.79 -532.99 -111.14 -1,723.96 -1,825.92 -2,154.43 -19.66%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.55 -0.64 -0.81 -0.42 -4.49 -4.97 -5.33 -31.48%
EPS Diluted -0.55 -0.64 -0.81 -0.41 -4.49 -4.97 -5.33 -31.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.